Raymond W. Cohen
Chief Executive Officer
Mr. Cohen is an accredited public company director with over 30 years of experience in leading medical device companies and serving on the boards at a number of private and publicly traded life science companies. From 2010 to 2012, he served as CEO of privately-held venture capital backed Vessix Vascular which was acquired by Boston Scientific in November 2012. He spent nearly a decade as Chairman & CEO of Nasdaq-listed Cardiac Science Inc. ranked as the 4th fastest growing company in U.S. in 2004. Currently, Mr. Cohen serves as the Chairman of the board of directors at Seattle-based BioLife Solutions (Nasdaq: BLFS – preservation media for human cells), UK-based Lombard Medical (Nasdaq: EVAR – endovascular AAA stent graft), UK-based Dysis Medical (system for detecting cervical cancer). He also serves as an independent director, chairman of the compensation committee and member of the audit committee of Henderson, NV and Irvine, CA-based Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI – Oncology drugs). Mr. Cohen also served on the boards of two firms that successfully executed an exit transaction in 2017, Zurich-based LifeWatch (LIFE.SW) sold to Biotelemetry (Nasdaq: BEAT) and Westminster, CO-based privately held Syncroness, Inc. (contract engineering) sold to ALTEN Group, a French multi-billion dollar engineering services company.
Dan L. Dearen
Chief Operating & Financial Officer
Mr. Dearen has over 20 years of experience in medical devices and pharmaceutical industries. Previously Chief Operating and Financial Officer at Vessix Vascular, Mr. Dearen was responsible for integration following the acquisition of Vessix by Boston Scientific. Prior to that, Mr. Dearen was CFO of a number of life science and venture capital firms including Miraval Holding, Q3DM, Fairbanks Systems Group, ESI Software, Medication Delivery Devices and positions with Ventana Growth Funds.
Chief Product Development Officer
Mr. Mathur has over 25 years experience in developing Class III therapeutic medical devices. He previously led product development efforts for Boston Scientific, Vessix Vascular, Cardiac Science and Medstone Intl.
Guangqiang (Jay) Jiang, Ph.D.
Chief Technology Officer
Dr. Jiang is a seasoned technical executive with a 15-year track record of developing complex, implantable Class III medical devices. He was previously VP of R&D at the Alfred Mann Foundation. Dr Jiang was elected to the American Institute for Medical and Biological Engineering (AIMBE)’s College of Fellows and served as Principal Investigator on several government contracts. Dr Jiang holds a Ph.D. in Biomedical Engineering from the University of Southern California.
Michael V. Williamson, Esq.
Sr. Vice President, General & IP Counsel
Mr. Williamson is a lawyer and mechanical engineer by training. He was previously General & IP and counsel at Vessix Vascular. Expert in medical device intellectual property, legal transactions, regulatory, product development and operations, Mr. Williamson worked previously at Cordis Corporation/Nitinol Devices and Components.
Vice President, Operations and Quality
Mr. Sama brings more than 10 years of Class III medical device experience implementing lean Operations and compliant Quality Systems. Prior to Axonics, Mr. Sama was the Director of Operations and Quality at Vessix Vascular Inc., and then the Director of Program Management at Boston Scientific. Mr. Sama holds a Master’s degree in Biomedical Engineering from University of Southern California and an MBA from University of California, Irvine.
John Woock, Ph.D.
Vice President, Global Marketing and Clinical Operations
Dr. Woock has a Ph.D. in Biomedical Engineering from Duke University, focused on neural stimulation to control urinary function. He is the co-inventor of several technologies in the field of urology. Dr Woock was previously a Stanford Biodesign Fellow and an Engagement Manager at McKinsey & Company.
Vice President, Electrical Engineering
Mr. Nassif brings over 30 years of product development experience, mainly in the field of medical devices. He has been a creative force through his previous leadership roles at Carefusion, Cardiac Science and Vessix Vascular.
Senior Director, Business Development and Market Access
Mrs. Finiels brings 5 years experience from the venture capital industry. She was previously an Associate at Edmond de Rothschild Investment Partners, where she worked on medical devices and biotech investments. Mrs. Finiels holds a MSc in Biochemistry from the University of Montpellier, France and the University of Oxford, and a MSc in Management from EMLyon Business School.